Navigation Links
New cancer drug shows promise for treating advanced melanoma
Date:6/2/2013

Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.

The results were presented at the 2013 meeting of the American Society of Clinical Oncology today in Chicago by Dr. Antoni Ribas, professor of medicine in the UCLA division of hematology-oncology, who led the research. Following Ribas' presentation, the study was published online ahead of press in the New England Journal of Medicine.

The results are from the first clinical trial of the drug lambrolizumab (MK3475), which was discovered and developed by Merck. Researchers analyzed 135 patients with advanced metastatic melanoma who were divided into three groups with different treatment regimens.

Overall, 38 percent of patients taking lambrolizumab saw confirmed improvement of their cancer across all dose levels. Of those taking the lowest dose of lambrolizumab, 25 percent showed improvement, while 52 percent of those who received the highest dose improved. The rate of any tumor response across all patients was 77 percent. Researchers have not yet determined the average duration of response to the drug, because only five patients who had initial responses were taken off the study after their cancers got worse. To date, the longest response has been over one year.

Side effects with lambrolizumab are usually mild and easily managed. These include fatigue, fever, skin rash, loss of skin color and muscle weakness. Thirteen percent of patients had side effects that were more severe, including inflammation of the lung or kidney, and thyroid problems.

"This study is showing the highest rate of durable melanoma responses of any drug we have tested thus far for melanoma, and it is doing it without serious side effects in the great majority of patients," Ribas said.

'/>"/>
Contact: Shaun Mason
smason@mednet.ucla.edu
University of California - Los Angeles
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Some patients with treatment-resistant colorectal cancers may have a new option
2. Abnormalities in HER2 gene found in wide variety of advanced cancers
3. New Drug May Slow Advanced Ovarian Cancer
4. Doubling Time on Tamoxifen Cuts Odds for Breast Cancers Return: Study
5. MGH-led studies shed new light on targeted lung cancer therapy
6. No increased risk of infection for long-term sex partners of people with HPV-related oral cancers
7. Likelihood of Spousal HPV Oral Infection, Predictors of Melanoma and Throat Cancer, Preventing Cancer Readmissions
8. Spousal oral HPV, predictors of melanoma and throat cancer, preventing cancer readmissions
9. New drug improves progression-free survival, shrinks tumors in rare cancer for first time
10. Voices Against Brain Cancer Comments on New Potential Development in Brain Cancer Treatment
11. National Camp Series (NCS) Associate Chris Husby Joins Kicking For The Dream’s Effort to Fight Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014 The MedTech industry is gearing up ... owned subsidiary of PartnerTech AB of Sweden, is prepared to ... additional ISO Certification. , All signs point to growth in ... likelihood of a repeal of the excise tax originally levied ... is anticipating annual growth of 9.3% and PartnerTech Inc. is ...
(Date:12/22/2014)... December 22, 2014 TheHardwareCity.com now stocks ... with many useful features. Customers of the large online ... the new gloves delivered to their home or workplace ... hand tools that incorporate heavy duty magnets, which make ... allows workers to store metal parts on the back ...
(Date:12/22/2014)... December 22, 2014 NAPW ... Professional Woman of the Year. She is recognized with ... largest, most recognized networking organization of professional women in ... National Association of Professional Women is a vibrant networking ... Chapters. , Ms. Kreider is passionate and committed to ...
(Date:12/22/2014)... Parker & Sons, Inc. a reliable and dependable ... services reports a record number of favorable reviews and ... As a company that has served the greater Phoenix ... is a business that is focused on excellent credibility ... top quality companies in Arizona that are focused on ...
(Date:12/21/2014)... December 22, 2014 BellasDress.com offers a ... for women. Today, it announces its BellasDress Christmas ... at its online store. , BellasDress is a famous ... to its fans through a series of promotions. The ... every customer. , “We are proud of offering ...
Breaking Medicine News(10 mins):Health News:PartnerTech Inc. Poised for Growth in MedTech 2Health News:MagnoGrip Pro Utility Magnetic Gloves on Sale at TheHardwareCity.com 2Health News:National Association of Professional Women Announces Cheryl A. Kreider, President / CEO of Kreider Health Solutions, LLC, a 2014 Professional Woman of the Year 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 3Health News:BellasDress.com Announces its BellasDress Christmas Sale 2
... sleep deprivation could affect the functioning of brain cells. This ... University. They conducted this study on rats. ,The ... sleep was deprived for 72 hours and the other one ... in the first group affected a region in the brain ...
... scientists have found a set of "master switches" that ... Unlocking the switches' code may one day enable scientists ... with cancer and other bone marrow disorders. ... gene level, but farther down the protein production line ...
... been shed on proteorhodopsin, the light-sensitive protein found in ... of Energy’s Lawrence// Berkeley National Laboratory (Berkeley Lab) and ... when the ability to respire oxygen is impaired, bacterium ... carry out vital life processes. ,“Our ...
... anti-Ro and anti-La antibodies revealed development of heart problems ... ,There is an increased risk of fetal ... rheumatic diseases, according to an abstract presented by Yale ... Medicine Conference February 9 in San Francisco. ...
... scientists, amongst which were members of the University Clinic ... Applied Medical Research// (CIMA) of the same university has ... with acute lymphoblastic leukemia. ,The conclusions of ... Blood, of the American Haematology Association. ,It ...
... for HIV infection, according to investigators from Sheffield, writing ... researchers conducted// a meta-analysis of studies exploring this issue. ... between smoking and progression to AIDS failed to find ... recognition that smoking can increase the risk of infections. ...
Cached Medicine News:Health News:Master Switches Found for Adult Blood Stem Cells 2Health News:Shedding New Light on Proteorhodopsin 2Health News:A New Treatment Discovered For Acute Lymphoblastic Leukemia 2Health News:Smoking Increases Risk of HIV Acquisition 2
(Date:12/17/2014)... AMSTERDAM and SAN DIEGO , ... PHG ; AEX: PHIA) and Volcano Corporation (NASDAQ: ... and measurement solutions for cardiovascular applications, today announced that they ... agreement, Philips will commence a tender offer to acquire all ... 18.00 per share, or a total equity purchase price of ...
(Date:12/17/2014)... , Dec. 17, 2014  Northstar Global ... Depository Trust Company (DTC) has made their final ... Chill on the Company,s stock effective December 15, ... common stock for depository and book entry transfer ... Company is now once again fully "DTC Eligible", ...
(Date:12/17/2014)... , Dec. 17, 2014  ImmunoCellular Therapeutics, ... US Patent and Trademark Office (USPTO) has issued ... a dendritic cell-based immunotherapeutic vaccine targeting six tumor ... claims of US Patent No. 8,871,211, which issued ... cancer by administering a dendritic cell composition comprising ...
Breaking Medicine Technology:Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
... A new highly sensitive and specific ... ELISA based on the detection of autoantibodies ... modified arginine residues in human serum or ... RA, the Anti-CCP assay provides an additional ...
... Rapid Plasma Reagin ... rapid detection and quantitative ... serum or plasma. Uses ... to detect reagin. Kits ...
Hemagglutination slide test for the qualitative detection and quantitative determination of antibodies to streptococcal extracellular antigens in serum, plasma, or whole blood....
Test for the quantitative determination of antideoxyribonuclease-B (ADNase-B) in serum....
Medicine Products: